Johnson & Johnson (NYSE:JNJ) today shared new clinical findings from a novel U.S. pilot study of its Abiomed unit’s Impella 5 ...

Background Patients with adult congenital heart disease (ACHD) frequently develop late complications despite early surgical ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

Demographic, systemic sclerosis (SSc)-specific, and cardiac factors raised the risk for left ventricular systolic dysfunction (LVSD) in a study of patients with SSc. Researchers used the Johns Hopkins ...

Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

Rochester, Minnesota—Left ventricular dysfunction is the medical name for a weak heart pump. It's a condition that impacts about 9% of people over the age of 60. Paul Friedman, M.D., a cardiologist at ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

Please provide your email address to receive an email when new articles are posted on . HF and LV dysfunction affect about 9% of adults aged 60 years and older, and there are effective treatments to ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...